STUDY ON AKKARAM(STOMATITIS)WITH EVALUATION OF SIDDHA DRUG"AKKARAM ENNAI"

Phase II non randomized clinical study on akkaram (stomatitis) with evaluation of siddha trial drug "akkaram ennai"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030644

Enrollment

Registered

2021-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K121- Other forms of stomatitis

Interventions

Intervention1: AKKARAM ENNAI: 5-10ML of akkaram ennai is given orally for twice a day after a meal for 7-14 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: ULCERATION IN THE ORAL CAVITY BLISTERS IN MOUTH FOWL SMELLING BREATH FEVER

Exclusion criteria

Exclusion criteria: OTITIS MEDIA SINUSITIS ORAL ULCER MAY BE DUE TO CANCER GROWTH ACUTE CATARRHAL RHINITS

Design outcomes

Primary

Measure	Time frame
REDUCTION IN CLINICAL SYMPTOMSTimepoint: 7 TO 14 DAYS	—

Secondary

Measure	Time frame
COMPARING SAFETY PARAMETERS BEFORE AND AFTER TREATMENTTimepoint: 7 TO 14 DAYS	—

Countries

India

Contacts

Public ContactDr Sridevi L

Government siddha medical college

ranimoorthybsms19@gmail.com9442286863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026